Intravenous Infusion of Bone Marrow–Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats

Article English OPEN
Matsuda, Yohei; Sasaki, Masanori; Kataoka-Sasaki, Yuko; Takayanagi, Akio; Kobayashi, Ko; Oka, Shinichi; Nakazaki, Masahito; Masumori, Naoya; Kocsis, Jeffery D.; Honmou, Osamu;
(2017)
  • Publisher: Elsevier
  • Journal: Sexual Medicine,volume 6,issue 1,pages49-57 (issn: 2050-1161, eissn: 2050-1161)
  • Related identifiers: pmc: PMC5815969, doi: 10.1016/j.esxm.2017.10.005
  • Subject: Other systems of medicine | Mesenchymal Stem Cell | R | RZ201-999 | Medicine | Cavernous Nerve Injury | Erectile Dysfunction

Introduction: Intravenous preload (delivered before cavernous nerve [CN] injury) of bone marrow–derived mesenchymal stem cells (MSCs) can prevent or decrease postoperative erectile dysfunction (J Sex Med 2015;12:1713–1721). In the present study, the potential therapeuti... View more
Share - Bookmark